Urinary Angiotensinogen Could Be a Prognostic Marker of Renoprotective Effects of Alogliptin in Patients with Type 2 Diabetes

Table 4

Laboratory data at the entry partitioned by the cutoff value of UAGTCR before treatments.

Group	High	Low	value
HbA1c (NGSP) (%)	7.26 ± 0.15	7.23 ± 0.14	= 0.89
eGFR (mL/min/1.73 m^2)	76.6 ± 4.6	72.3 ± 4.3	= 0.50
Systolic blood pressure (mmHg)	143.6 ± 4.3	137.9 ± 4.0	= 0.33
Diastolic blood pressure (mmHg)	77.0 ± 2.5	78.4 ± 2.4	= 0.68